Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyeongwon-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Eur Radiol. 2019 Sep;29(9):4635-4647. doi: 10.1007/s00330-019-06036-8. Epub 2019 Feb 26.
Although ultrasound (US) is a standard modality for the assessment of cervical lymph node metastasis in patients with thyroid cancer, there is an increasing trend in the number of articles describing the use of contrast-enhanced computed tomography (CT). The purpose of this systematic review and meta-analysis was to evaluate the diagnostic performance of CT in the diagnosis of metastatic cervical lymph nodes and to identify the parameters responsible for heterogeneity in diagnostic performance.
Ovid-MEDLINE and EMBASE databases were searched up to May 22, 2018, for studies on the diagnostic performance of CT. The pooled sensitivity and specificity of all studies were calculated. In addition, subgroup analysis and meta-regression analysis were performed to evaluate factors responsible for heterogeneity.
Seventeen (6378 patients, 11,590 lymph nodes) studies were included. The pooled sensitivity was 55% (95% CI, 47-63%), and the pooled specificity was 87% (95% CI, 90-95%). Higgins I statistic demonstrated substantial heterogeneity in the sensitivity (I = 96.3%) and specificity (I = 93.8%). In a per-neck level subgroup analysis, the Higgins I statistic demonstrated reduced heterogeneity in both sensitivity and specificity. In the meta-regression analysis, variation in the CT protocols, such as contrast amount, scan phase, and reconstruction slice thickness, was a statistically significant factor causing heterogeneity.
CT demonstrated acceptable diagnostic performance in the pre- and postoperative diagnosis of metastatic cervical lymph nodes in patients with thyroid cancer. Variation in the CT protocols was a main factor causing heterogeneity among the included studies.
• The role of contrast-enhanced computed tomography (CT) needs to be reassessed. • CT demonstrated acceptable diagnostic performance in the diagnosis of metastatic cervical lymph nodes in patients with thyroid cancer in the meta-analysis. • Variation in the CT protocols was a main factor causing heterogeneity in the meta-regression analysis.
尽管超声(US)是评估甲状腺癌患者颈部淋巴结转移的标准方式,但描述使用对比增强计算机断层扫描(CT)的文章数量呈上升趋势。本系统评价和荟萃分析的目的是评估 CT 在诊断转移性颈部淋巴结中的诊断性能,并确定导致诊断性能异质性的参数。
截至 2018 年 5 月 22 日,在 Ovid-MEDLINE 和 EMBASE 数据库中搜索关于 CT 诊断性能的研究。计算所有研究的合并敏感性和特异性。此外,还进行了亚组分析和荟萃回归分析,以评估导致异质性的因素。
纳入了 17 项(6378 例患者,11590 个淋巴结)研究。合并敏感性为 55%(95%CI,47-63%),合并特异性为 87%(95%CI,90-95%)。Higgins I 统计量显示敏感性(I=96.3%)和特异性(I=93.8%)存在较大异质性。在按颈部水平的亚组分析中,敏感性和特异性的 Higgins I 统计量显示异质性降低。在荟萃回归分析中,CT 方案的变化,如造影剂用量、扫描阶段和重建层厚,是导致异质性的统计学显著因素。
CT 在甲状腺癌患者术前和术后诊断转移性颈部淋巴结方面具有可接受的诊断性能。CT 方案的变化是纳入研究中异质性的主要因素。
需要重新评估增强 CT 的作用。
在荟萃分析中,CT 在诊断甲状腺癌患者转移性颈部淋巴结方面表现出可接受的诊断性能。
CT 方案的变化是荟萃回归分析中导致异质性的主要因素。